TPP1 and neoplasm: This corroborates the data reported in Figure 2F–I, pointing to an increased proportion of NK cells inside the tumour upon ITPP treatment and increased activated NK cells (CD49b+CD226+),46 as well as invasion of the tumour, as opposed to non‐treated tumours where NK cells were found in the vessels (Figure 2A–D).